Harmonic Discovery uses a machine learning platform to facilitate drug discovery. The platform combines several aspects of traditional discovery, such as examining the atom and bond makeup of kinase drugs, according to a Sept. 8 Harmonic Discovery news release.
The funding round was led by Innovation Endeavors with participation from Fifty Years, Y Combinator, Boom Capital and Caffeinated Capital.
